Related references
Note: Only part of the references are listed.Influenza antivirals currently in late-phase clinical trial
Paulina Koszalka et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation
A. Waghmare et al.
BLOOD (2016)
Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts
Koert J. Stittelaar et al.
VIRUSES-BASEL (2016)
Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS)
Pieter L. Fraaij et al.
ANTIVIRAL THERAPY (2015)
Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses
Doug H. Cheung et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza
Jung-Wan Yoo et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Identification of Amino Acid Substitutions Supporting Antigenic Change of Influenza A(H1N1) pdm09 Viruses
Bjoern F. Koel et al.
JOURNAL OF VIROLOGY (2015)
Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets
Jessica A. Belser et al.
VIROLOGY (2015)
Selecting vaccine strains for H3N2 human influenza A virus
Yoshiyuki Suzuki
META GENE (2015)
The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2014)
Severity of Clinical Disease and Pathology in Ferrets Experimentally Infected with Influenza Viruses Is Influenced by Inoculum Volume
Ian N. Moore et al.
JOURNAL OF VIROLOGY (2014)
Antiviral combinations for severe influenza
Jake Dunning et al.
LANCET INFECTIOUS DISEASES (2014)
Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir
Anthony C. Marriott et al.
PLOS ONE (2014)
Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1) pdm09 Influenza Viruses
Jeff Butler et al.
PLOS PATHOGENS (2014)
Global Assessment of Resistance to Neuraminidase Inhibitors, 2008-2011: The Influenza Resistance Information Study (IRIS)
Richard J. Whitley et al.
CLINICAL INFECTIOUS DISEASES (2013)
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
Jennifer L. McKimm-Breschkin
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Molecular Assays for Quantitative and Qualitative Detection of Influenza Virus and Oseltamivir Resistance Mutations
Erhard van der Vries et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
Erhard van der Vries et al.
PLOS PATHOGENS (2013)
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods
Ha T. Nguyen et al.
ANTIVIRAL THERAPY (2012)
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
Aeron C. Hurt et al.
LANCET INFECTIOUS DISEASES (2012)
Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in Ferrets
Judith M. A. van den Brand et al.
PLOS ONE (2012)
Viral Infections in Immunocompromised Patients
Janet Englund et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
Su-Mi Choi et al.
BLOOD (2011)
Oseltamivir Shortens Hospital Stays of Critically Ill Children Hospitalized With Seasonal Influenza A Retrospective Cohort Study
Susan E. Coffin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Antivirals and resistance: influenza virus
Michael G. Ison
CURRENT OPINION IN VIROLOGY (2011)
Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age: A Randomized Controlled Trial
Santtu Heinonen et al.
CLINICAL INFECTIOUS DISEASES (2010)
End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease
Michael G. Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
Deepali Kumar et al.
LANCET INFECTIOUS DISEASES (2010)
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
Xavier Duval et al.
PLOS MEDICINE (2010)
Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza
Nelson Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
Ken M. Kunisaki et al.
LANCET INFECTIOUS DISEASES (2009)
Outcome of influenza infection managed with oseltamivir in lung transplant recipients
Michael G. Ison et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
Elena A. Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child
Mariana Baz et al.
CLINICAL INFECTIOUS DISEASES (2006)
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
J McKimm-Breschkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Influenza virus carrying an R292K mutation in the neuraminidase gene is an transmitted in ferrets
ML Herlocher et al.
ANTIVIRAL RESEARCH (2002)
Share Paper
